Startups
Achilles Therapeutics

Achilles Therapeutics

https://achillestx.com

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

Summary

Seedtable Score
  • 50
Locations
Company Size
  • 101 to 250 employees
Last Stage Round
  • Series C
Industry

Total funding Amount

$210M

Fundraising History

  • Nov 09 '20 Series C
    $68M
  • Sep 03 '19 Series B
    $120M
  • Sep 28 '16 Seed
    $17M

Investors

  • Boxer Capital
    Series C
  • Forbion Capital Partners
    Series B
  • Invus
    Series B
  • Syncona Partners LLP
    Seed
  • AlbionVC
    Seed
  • Sixth Element Capital
    Seed